Cargando…

Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster

SIMPLE SUMMARY: Anti-CD20 treatments produce a prolonged B-cell aplasia that is responsible for a suboptimal humoral response after vaccination against SARS-CoV-2, even months after receiving therapy. However, there is scarce information on the cellular immune response. In this study, we analyzed bo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torres, Montserrat, Corona, Magdalena, Rodríguez-Mora, Sara, Casado-Fernández, Guiomar, Zurdo-Castronuño, Alejandro, Mateos, Elena, Ramos-Martín, Fernando, Sánchez-Menéndez, Clara, Murciano-Antón, María Aranzazú, García-Pérez, Javier, Alcamí, José, Pérez-Olmeda, Mayte, Coiras, Mayte, López-Jiménez, Javier, García-Gutiérrez, Valentín
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688562/ https://www.ncbi.nlm.nih.gov/pubmed/36428631 http://dx.doi.org/10.3390/cancers14225537

Ejemplares similares

Early Cellular and Humoral Responses Developed in Oncohematological Patients after Vaccination with One Dose against COVID-19
por: Rodríguez-Mora, Sara, et al.
Publicado: (2022)

Strong Cellular Immune Response, but Not Humoral, against SARS-CoV-2 in Oncohematological Patients with Autologous Stem Cell Transplantation after Natural Infection
por: Vigón, Lorena, et al.
Publicado: (2022)

Persistent Immunity against SARS-CoV-2 in Individuals with Oncohematological Diseases Who Underwent Autologous or Allogeneic Stem Cell Transplantation after Vaccination
por: Rodríguez-Mora, Sara, et al.
Publicado: (2023)

Characterization of the Humoral and Cellular Immune Response Against the Natural Infection By Sars-Cov-2 in Oncohematological Patients with Post-COVID19 Autologous Transplantation
por: Sánchez-Tornero, Adrián, et al.
Publicado: (2021)

Characterization of the Early Humoral and Cellular Response Developed in Oncohematological Patients Post-Vaccination with One Dose Against COVID-19
por: Corona De Lapuerta, Magdalena, et al.
Publicado: (2021)

Regular Humoral and Cellular Immune Responses in Individuals with Chronic Myeloid Leukemia Who Received a Full Vaccination Schedule against COVID-19
por: Rodríguez-Mora, Sara, et al.
Publicado: (2023)

PB1944: INDIVIDUALS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA SHOW IMPAIRED HUMORAL BUT NORMAL CELLULAR IMMUNE RESPONSES AFTER RECEIVING A COMPLETE VACCINATION SCHEDULE AGAINST SARS-COV-2
por: Sánchez-Menéndez, Clara, et al.
Publicado: (2023)

Analysis of Immunological and Clinical Response to Vaccination Against Sars-COV-2 in Patients with Chronic Myeloid Leukemia
por: ZURDO Castronuño, Alejandro, et al.
Publicado: (2022)

Molecular mechanisms involved in HIV latency and implications for HIV treatment and eradication
por: Alcami, Jose, et al.
Publicado: (2010)

Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU
por: Vigón, Lorena, et al.
Publicado: (2021)

PB2159: CHARACTERIZATION OF THE IMMUNE RESPONSE DEVELOPED IN PATIENTS WITH MULTIPLE MYELOMA AFTER RECEIVING TWO DOSES OF THE VACCINE AGAINST SARS-COV-2
por: Perez, Laura, et al.
Publicado: (2023)

Caspase-3-mediated cleavage of p65/RelA results in a carboxy-terminal fragment that inhibits IκBα and enhances HIV-1 replication in human T lymphocytes
por: Coiras, Mayte, et al.
Publicado: (2008)

Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity
por: Vigón, Lorena, et al.
Publicado: (2021)

IL-7 Induces SAMHD1 Phosphorylation in CD4+ T Lymphocytes, Improving Early Steps of HIV-1 Life Cycle
por: Coiras, Mayte, et al.
Publicado: (2016)

Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic Biomarkers
por: Galán, Miguel, et al.
Publicado: (2022)

Identification of Immunological Parameters as Predictive Biomarkers of Relapse in Patients with Chronic Myeloid Leukemia on Treatment-Free Remission
por: Vigón, Lorena, et al.
Publicado: (2020)

Transcriptomic Evidence of the Immune Response Activation in Individuals With Limb Girdle Muscular Dystrophy Dominant 2 (LGMDD2) Contributes to Resistance to HIV-1 Infection
por: Diez-Fuertes, Francisco, et al.
Publicado: (2022)

Basal shuttle of NF-κB/IκBα in resting T lymphocytes regulates HIV-1 LTR dependent expression
por: Coiras, Mayte, et al.
Publicado: (2007)

Functional Consequences for Apoptosis by Transcription Elongation Regulator 1 (TCERG1)-Mediated Bcl-x and Fas/CD95 Alternative Splicing
por: Montes, Marta, et al.
Publicado: (2015)

Sustained Cytotoxic Response of Peripheral Blood Mononuclear Cells from Unvaccinated Individuals Admitted to the ICU Due to Critical COVID-19 Is Essential to Avoid a Fatal Outcome
por: Casado-Fernández, Guiomar, et al.
Publicado: (2023)

PKCθ and HIV-1 Transcriptional Regulator Tat Co-exist at the LTR Promoter in CD4(+) T Cells
por: López-Huertas, María Rosa, et al.
Publicado: (2016)

Modifications in host cell structure and functions mediated by Tat intracellular expression are greatly dependent on the second exon
por: López-Huertas, María Rosa, et al.
Publicado: (2009)

The mutation of Transportin 3 gene that causes limb girdle muscular dystrophy 1F induces protection against HIV-1 infection
por: Rodríguez-Mora, Sara, et al.
Publicado: (2019)

Association between HLA-C alleles and COVID-19 severity in a pilot study with a Spanish Mediterranean Caucasian cohort
por: Vigón, Lorena, et al.
Publicado: (2022)

Transcription elongation regulator 1 (TCERG1) regulates competent RNA polymerase II-mediated elongation of HIV-1 transcription and facilitates efficient viral replication
por: Coiras, Mayte, et al.
Publicado: (2013)

Hydroxytyrosol: a new class of microbicide displaying broad anti-HIV-1 activity
por: Bedoya, Luis M., et al.
Publicado: (2016)

Identification of platelet refractoriness in oncohematologic patients
por: Ferreira, Aline Aparecida, et al.
Publicado: (2011)

Biosensors in Clinical Practice: Focus on Oncohematology
por: Fracchiolla, Nicola S., et al.
Publicado: (2013)

The CCR5-antagonist Maraviroc reverses HIV-1 latency in vitro alone or in combination with the PKC-agonist Bryostatin-1
por: López-Huertas, María Rosa, et al.
Publicado: (2017)

Analysis of the -398C/T polymorphism in the perforin gene in oncohematological patients
por: Garcia, Fernanda Bernadelli, et al.
Publicado: (2011)

A Founder Effect Led Early SARS-CoV-2 Transmission in Spain
por: Díez-Fuertes, Francisco, et al.
Publicado: (2021)

Changing epidemiology of catheter-related bloodstream infections in neutropenic oncohematological patients
por: Lendak, Dajana, et al.
Publicado: (2021)

Non-EBV-Related Aggressive NK-Cell Leukemia: An Oncohematological Great Imitator
por: Lepe-Zuniga, Jose L., et al.
Publicado: (2018)

Beneficial Effect of Short-Term Supplementation of High Dose of Vitamin D(3) in Hospitalized Patients With COVID-19: A Multicenter, Single-Blinded, Prospective Randomized Pilot Clinical Trial
por: Cervero, Miguel, et al.
Publicado: (2022)

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
por: Borobia, Alberto M, et al.
Publicado: (2021)

Towards Understanding the Pathogenicity of DROSHA Mutations in Oncohematology
por: Bug, Dmitrii S., et al.
Publicado: (2021)

Intracellular expression of Tat alters mitochondrial functions in T cells: a potential mechanism to understand mitochondrial damage during HIV-1 replication
por: Rodríguez-Mora, Sara, et al.
Publicado: (2015)

Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D
por: Torres, Montserrat, et al.
Publicado: (2022)

Pilot Study on the Cost of Some Oncohematology Diseases in Bulgaria
por: Tachkov, Konstantin, et al.
Publicado: (2019)

Rituximab: Humoral immunodeficiency: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mkk0s2ot9k4m7042oj7ae29nkn